APPF vs EW · P/E 43, rev $794.2M vs P/E 47, rev $1.39B
Appfolio Inc (APPF) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Appfolio Inc (APPF) is a software - application company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported APPF revenue for 2024-12-31 was $794.2M. Net income was $204.1M. Revenue was up 28.0% from 2023-12-31 to 2024-12-31. APPF currently screens at market cap $8.38B and trailing P/E 43.3.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
APPF currently screens at market cap $8.38B and trailing P/E 43.3. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the APPF and EW stock pages for the full models.
Not investment advice.